INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Grant or awardVerified data

Glass Mitchell reported QCLS

Director, Chief Medical Officer · Q/C TECHNOLOGIES, INC. · Q/C TECHNOLOGIES, INC. — Employee Stock Option (Right to Buy)

Side
A
Value
—
Shares
50.0K
Price
—
Executed
Apr 13, 2026
Disclosed
Apr 15, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 13 executedApr 15, 2026 disclosed

QCLS · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · QCLS

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    21
    SJ
    Silverman JoshuaDirector, Executive Chairman
    QCLSQ/C TECHNOLOGIES, INC.
    Grant or award
    		A—
    162.2K sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    SJ
    Silverman JoshuaDirector, Executive Chairman
    QCLSQ/C TECHNOLOGIES, INC.
    Grant or award
    		A—
    100.0K sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    FS
    Friscia StephenDirector
    QCLSQ/C TECHNOLOGIES, INC.
    Grant or award
    		A—
    50.0K sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    WJ
    White Billy JoeDirector
    QCLSQ/C TECHNOLOGIES, INC.
    Grant or award
    		A—
    50.0K sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BB
    Bernstein BruceDirector
    QCLSQ/C TECHNOLOGIES, INC.
    Grant or award
    		A—
    50.0K sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    9
    VS
    Voss Chelsea SierraDirector
    QCLSQ/C TECHNOLOGIES, INC.
    Grant or award
    		A—
    50.0K sh
    		Apr 13, 2026Apr 15, 2026
    traded Apr 13, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001493152-26-016911
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 13, 2026
    Published
    Apr 15, 2026
    Ingested by INSIDER
    Nov 5, 04:04 UTC
    Last re-read
    Nov 5, 04:04 UTC

    Extracted facts

    Filer
    Glass Mitchell
    Role
    Director, Chief Medical Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Q/C TECHNOLOGIES, INC. — Employee Stock Option (Right to Buy)
    Ticker
    QCLS
    Shares
    50.0K
    Price per share
    $0
    Execution date (reported)
    Apr 13, 2026
    Owned after transaction
    50.0K shares
    Days from execution to publication
    2

    What this establishes

    Glass Mitchell filed this Form 4 reporting a grant or award of QCLS on Apr 13, 2026. It became public on Apr 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, Chief Medical Officer
    Glass Mitchellcik:0002023649
    Issuer
    Q/C TECHNOLOGIES, INC.cik:0001321834

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.